Hypogonadotropic hypogonadism as a model of post-natal testicular anti-Müllerian hormone secretion in humans

Molecular and Cellular Endocrinology

Volumn 211, Issue 1-2, 2003, Pages 51-54

  Young, Jacques ^a   Rey, Rodolfo ^b   Schaison, Gilbert ^a   Chanson, Philippe ^a  

^a BICÊTRE HOSPITAL   (France)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Anti M llerian hormone; Gonadotropins; Hypogonadism; Testosterone

Indexed keywords

CHORIONIC GONADOTROPIN; MUELLERIAN INHIBITING FACTOR; TESTOSTERONE;

CONFERENCE PAPER; GONADOTROPIN DEFICIENCY; GONADOTROPIN RELEASE; HORMONAL REGULATION; HORMONE ACTION; HORMONE DETERMINATION; HORMONE INHIBITION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; INTERMETHOD COMPARISON; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE RELEASE;

EID: 0344515657     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2003.09.020     Document Type: Conference Paper

References (28)

1. Al-Attar L., Noel K., Dutertre M., Belville C., Forest M.G., Burgoyne P.S., Josso N., Rey R. Hormonal and cellular regulation of Sertoli cell anti-Müllerian hormone production in the post-natal mouse. J. Clin. Invest. 100:1997;1335-1343.
2. Anawalt B.D., Bebb R.A., Matsumoto A.M., Groome N.P., Illingworth P.J., McNeilly A.S., Bremner W.J. Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J. Clin. Endocrinol. Metab. 81:1996;3341-3345.
3. Behringer R.R., Cate R.L., Froelick G.J., Palmiter R.D., Brinster R.L. Abnormal sexual development in transgenic mice chronically expressing Müllerian-inhibiting substance. Nature. 345:1990;167-170.
4. Behringer R.R., Finegold M.J., Cate R.L. Müllerian-inhibiting substance function during mammalian sexual development. Cell. 79:1994;415-425.
5. Boyard R.M., Wu R.H., Kapen S., Hellman L., Weitzman E.D., Finkelstein J.W. Clinical and laboratory heterogeinity in idiopathic hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 43:1976;1268-1275.
6. Coutant R., Lumbroso S., Rey R., Lahlou N., Venara M., Rouleau S., Sultan C., Limal J.M. Macroorchidism due to autonomous hyperfunction of Sertoli cells and Gs-alpha gene mutation: an unusual expression of McCune-Albright syndrome ina prepubertal boy. J. Clin. Endocrinol. Metab. 86:2001;1778-1781.
7. Josso N., Picard J.Y., Imbeaud S., di Clemente N., Rey R. Clinical aspects and molecular genetics of the persistent Müllerian duct syndrome. Clin. Endocrinol. 47:1997;137-144.
8. Lee M.M., Donahoe P.K., Hasegawa T., Silverman B., Crist G.B., Best S., Hasegawa Y., Noto R.A., Schoenfeld D., MacLaughlin D.T. Müllerian Inhibiting substance in humans. Normal levels from infancy to adulthood. J. Clin. Endocrinol. Metab. 81:1996;571-576.
9. Lee M.M., Donahoe P.K., Silverman B.L., Hasegawa T., Hasegawa Y., Gustafson M.L., Chang Y., MacLaughlin D.T. Measurements of serum Müllerian inhibiting substance in the evaluation of children with non palpable gonads. N. Eng. J. Med. 336:1997;1480-1521.
10. Lee M.M., Seah C.C., Masiakos P.T., Sottas C.M., Preffer F.I., Donahoe P.K., MacLaughlin D.T., Hardy M.P. Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells. Endocrinology. 140:1999;2819-2827.
11. Lukas-Croisier C., Lasala C., Nicaud J., Bedecarrás P., Kumar T.R., Dutertre M., Matzuk M.M., Picard J.Y., Josso N., Rey R. Follicle stimulating hormone increases testicular anti-Müllerian hormone (AMH) production through Sertoli cell proliferation and a non-classical cyclic AMP-mediated activation of the AMH gene. Mol. Endocrinol. 17:2003;550-561.
12. Majumdar S., Winters S.J., Plant T.M. A study of the relative roles of follicle-stimulating hormone and luteinizing hormone in the regulation of testicular inhibin secretion in the rhesus monkey (Macaca mulatta). Endocrinology. 138:1997;1363-1373.
13. Mishina Y., Rey R., Finegold M.J., Matzuk M.M., Josso N., Cate R.L., Behringer R.R. Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev. 10:1996;2577-2587.
14. Narula A., Gu Y.Q., O'Donnell L., Stanton P.G., Robertson D.M., McLachlan R.I., Bremner W.J. Variability in sperm suppression during testosterone administration to adult monkeys is related to follicle timulating hormone suppression and not to intratescular androgens. J. Clin. Endocrinol. Metab. 87:2002;3399-3409.
15. Pasqualini T., Chemes H., Rivarola M.A. Testicular testosterone levels during puberty in cryptorchidism. Clin. Endocrinol. 15:1981;545-554.
16. Pitteloud N., Hayes F.J., Boepple P.A., DeCruz S., Seminara S.B., MacLaughlin D.T., Crowley W.F. Jr. The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 87:2002;152-160.
17. Racine C., Rey R., Forest M.G., Louis F., Ferré A., Huhtaniemi I., Josso N., di Clemente N. Receptors for anti-Müllerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation. Proc. Natl. Acad. Sci. U.S.A. 95:1998;594-599.
18. Rey R. Endocrine, paracrine and cellular regulation of post-natal anti-Müllerian hormone secretion by Sertoli cells. Trends Endocrinol. Metab. 9:1998;271-276.
19. Rey R., Lordereau-Richard I., Carel J.C., Barbet P., Cate R.L., Roger M., Chaussain J.L., Josso N. Anti-Müllerian hormone and testosterone serum levels are inversely related during normal and precocious pubertal development. J. Clin. Endocrinol. Metab. 77:1993;1220-1226.
20. Rey R., Mebarki F., Forest M.G., Mowszowicz I., Cate R.L., Morel Y., Chaussain J.L., Josso N. Anti-Müllerian hormone in children with androgen insensitivity. J. Clin. Endocrinol. Metab. 79:1994;960-964.
21. Rey R., Belville C., Nihoul-Fékété C., Michel-Calemard L., Forest M.G., Lahlou N., Jaubert F., Mowszowicz I., David M., Saka N., Bouvattier C., Bertrand A.M., Lecointre C., Soskin S., Cabrol S., Crosnier H., Léger J., Lortat-Jacob S., Nicolino M., Rabl W., Toledo S.P., Bas F., Gompel A., Czernichow P., Chatelain R., Rappaport R., Morel Y., Josso N. Evaluation of gonadal function in 107 intersex patients by means of serum anti-Müllerian hormone measurement. J. Clin. Endocrinol. Metab. 84:1999;627-631.
22. Sáez J.M. Leydig cells: endocrine, paracrine, and autocrine regulation. Endocr. Rev. 5:1994;574-626.
23. Schaison G., Young J., Pholsena M., Nahoul K., Couzinet B. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 77:1993;1545-1549.
24. Simoni M., Gromoll J., Nieschlag E. The follicle stimulating hormone receptor: biochemistry, molecular biology, physiology and pathophysiology. Endocrinol. Rev. 18:1997;739-773.
25. Sriraman V., Niu E., Matias J.R., Donahoe P.K., MacLaughlin D.T., Hardy M.P., Lee M.M. Müllerian inhibiting substance inhibits testosterone synthesis in adult rats. J. Androl. 22:2001;750-758.
26. Takemaya M., Honjoh M., Kodama M. Testicular steroids in spermatic and peripheral veins after single injection of hCG in patients with varicocele. Arch. Androl. 24:1990;207-213.
27. Young J., Rey R., Couzinet B., Chanson P., Josso N., Schaison G. Anti-Müllerian hormone in patients with hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 84:1999;2696-2699.
28. Young J., Couzinet B., Chanson P., Loumaye E., Schaison G. Effects of human recombinant LH and FSH in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions. J. Clin. Endocrinol. Metab. 85:2000;3239-3244.